🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To determine the efficacy of SAR441344 as measured by r...
Status
Active Not Recruiting
Location
Center for Neurology and Spine- Site Number : 8400007
Start Date
2021-06-07
Trial ID
NCT04879628
Treatments Being Tested
GDX-44-014 - GDX-101 study was conducted in Japan including 2 cohorts (adul...
Status
Completed
Location
Meitetsu Hospital
Start Date
2023-07-21
Trial ID
NCT06010173
Treatments Being Tested
Elucirem (Gadopiclenol) is a new macrocyclic gadolinium-based contrast agen...
Status
Recruiting
Location
Johns Hopkins Center for Advanced Imaging and Research Science, located in the Science + Technology Park at 1812 Ashland Avenue, Baltimore, MD.
Start Date
2025-08-01
Trial ID
NCT05954559
Treatments Being Tested
This Phase II open-label, uncontrolled, multicenter trial is designed to in...
Status
Completed
Location
Cincinnatti Childrens Hospital
Start Date
2022-09-21
Trial ID
NCT05590884
Treatments Being Tested
The survival of patients with CNS metastases often remains limited to some ...
Status
Not Yet Recruiting
Location
University Hospital Zurich
Start Date
2026-09
Trial ID
NCT07492121
Treatments Being Tested
The fundamental aim of this study is to show that the novel contrast agent ...
Status
Suspended
Location
Columbia University Irving Medical Center
Start Date
2024-02-14
Trial ID
NCT06226129
Treatments Being Tested
This trial aimed to study the performance of Elucirem (gadopiclenol) in Dyn...
Status
Completed
Location
Országos Idegtudományi Intézet - Neuroonkológiai és Intracraniá
Start Date
2023-09-07
Trial ID
NCT06057168
This study will evaluate the efficacy and safety of Gadopiclenol, an FDA-ap...
Status
Recruiting
Location
University of Connecticut Health Center
Start Date
2025-03-25
Trial ID
NCT06846853
Treatments Being Tested